Article

Gerber Coburn names new president

South Windsor, CT-Clement Patry, Gerber Coburn's executive director of sales, will take over as president of the company effective Feb. 1.

South Windsor, CT-Clement Patry, Gerber Coburn's executive director of sales, will take over as president of the company effective Feb. 1.

Patry, who has more than 20 years' experience in the ophthalmic industry, will also serve as vice president of the parent company, Gerber Scientific Inc.

Patry will succeed John R. Hancock, who moves from president of Gerber Coburn to president of Gerber Technology, which provides integrated hardware and software automation solutions to the apparel and flexible materials industries. He will continue as a senior vice president of Gerber Scientific.

The changes come as Gerber Coburn expands its dedicated sales force to cover the wholesale lab market. For 18 years, the company had used a third-party sales network. Nearly 100 people will address the wholesale lab market with sales and service calls as part of the company's new focus on customer relations.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.